EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate

Ekaterina Laukhtina iD, Marco Moschini iD, Wojciech Krajewski iD, Jeremy Yuen-Chun Teoh iD, Guillaume Ploussard iD, Francesco Soria iD, Florian Roghmann iD, Mara Anna Muenker, Mathieu Roumiguie iD, Mario Alvarez-Maestro iD, Vincent Misrai iD, Alessandro Antonelli iD und 15 weitere

BJU International · 2023-05 · 131 (5) · 571-580

DOI: 10.1111/bju.15898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 03.10.2022. Verfasst von Ekaterina Laukhtina und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Transurethral Resection of Prostate, Prostatic Hyperplasia, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the oncological impact and adverse events of performing simultaneous transurethral resection of bladder tumour (TURB) and transurethral resection of the prostate (TURP), as evidence on the outcomes of simultaneous TURB for bladder cancer and TURP for obstructive benign prostatic hyperplasia is limited and contradictory. Patients and Methods Patients from 12 European hospitals treated with either TURB alone or simultaneous TURB and TURP (TURB+TURP) were retrospectively analysed. A propensity score matching (PSM) 1:1 was performed with patients from the TURB+TURP group matched to TURB‐alone patients. Associations between surgery approach with recurrence‐free (RFS) and progression‐free (PFS) survivals were assessed in Cox regression models before and after PSM. We performed a subgroup analysis in patients with risk factors for recurrence (multifocality and/or tumour size >3 cm).

Results

A total of 762 men were included, among whom, 76% (581) underwent a TURB alone and 24% (181) a TURB+TURP. There was no difference in terms of tumour characteristics between the groups. We observed comparable length of stay as well as complication rates including major complications (Clavien–Dindo Grade ≥III) for the TURB‐alone vs TURB+TURP groups, while the latest led to longer operative time ( P < 0.001). During a median follow‐up of 44 months, there were more recurrences in the TURB‐alone (47%) compared to the TURB+TURP group (28%; P < 0.001). Interestingly, there were more recurrences at the bladder neck/prostatic fossa in the TURB‐alone group (55% vs 3%, P < 0.001). TURB+TURP procedures were associated with improved RFS (hazard ratio [HR] 0.39, 95% confidence interval [CI] 0.29–0.53; P < 0.001), but not PFS (HR 1.63, 95% CI 0.90–2.98; P = 0.11). Within the PSM cohort of 254 patients, the simultaneous TURB+TURP was still associated with improved RFS (HR 0.33, 95% CI 0.22–0.49; P < 0.001). This was also true in the subgroup of 380 patients with recurrence risk factors (HR 0.41, 95% CI 0.28–0.62; P < 0.001).

Conclusion

In our contemporary cohort, simultaneous TURB and TURP seems to be an oncologically safe option that may, even, improve RFS by potentially preventing disease recurrence at the bladder neck and in the prostatic fossa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transurethral Resection of ProstateProstatic HyperplasiaUrinary Bladder NeoplasmsMaleHumansProstateRetrospective StudiesNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

#BladderCancer#UroBPH#blcsm#urooncBPHTURBTURPbladder cancersimultaneous

Autor:innen und Institutionen

  • Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Division of Experimental Oncology/Unit of Urology, Urological Research Institute, Milan, Italy.
  • Department of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wrocław Medical University, Wroclaw, Poland.
  • Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Urology, La Croix du Sud Hospital, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
  • Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Turin, Italy.

ORCID-Profile: Ekaterina Laukhtina, Marco Moschini, Wojciech Krajewski, Jeremy Yuen-Chun Teoh, Guillaume Ploussard, Francesco Soria, Florian Roghmann, Mathieu Roumiguie, Mario Alvarez-Maestro, Vincent Misrai, Alessandro Antonelli, Alessandro Tafuri, Giuseppe Simone, Riccardo Mastroianni, Hongda Zhao, Razvan-George Rahota, David D'Andrea, Keiichiro Mori, Simone Albisinni, Harun Fajkovic, Dmitry Enikeev, Francesco Montorsi, Shahrokh F Shariat, Benjamin Pradere

Zitieren

APA

Laukhtina, E., Moschini, M., Krajewski, W., Teoh, J. Y., Ploussard, G., Soria, F., Roghmann, F., Muenker, M. A., Roumiguie, M., Alvarez-Maestro, M., Misrai, V., Antonelli, A., Tafuri, A., Simone, G., Mastroianni, R., Zhao, H., Rahota, R. G., D'Andrea, D., Mori, K., …, & European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group (2023). Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate. BJU International, 131(5), 571-580. https://doi.org/10.1111/bju.15898

Vancouver

Laukhtina E, Moschini M, Krajewski W, Teoh JY, Ploussard G, Soria F, et al. Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate. BJU International. 2023;131(5):571-580. doi:10.1111/bju.15898

BibTeX
@article{Laukhtina2023,
  author = {Laukhtina, Ekaterina and Moschini, Marco and Krajewski, Wojciech and Teoh, Jeremy Yuen-Chun and Ploussard, Guillaume and Soria, Francesco and Roghmann, Florian and Muenker, Mara Anna and Roumiguie, Mathieu and Alvarez-Maestro, Mario and Misrai, Vincent and Antonelli, Alessandro and Tafuri, Alessandro and Simone, Giuseppe and Mastroianni, Riccardo and Zhao, Hongda and Rahota, Razvan-George and D'Andrea, David and Mori, Keiichiro and Albisinni, Simone and Karakiewicz, Pierre I and Fajkovic, Harun and Enikeev, Dmitry and Montorsi, Francesco and Shariat, Shahrokh F and Pradere, Benjamin and European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group, European Association of Urology - Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group},
  title = {Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate},
  journal = {BJU International},
  year = {2023},
  volume = {131},
  number = {5},
  pages = {571--580},
  doi = {10.1111/bju.15898}
}
Kostenlos starten →